Parkin expression reverses mitochondrial dysfunction in fused in sarcoma-induced amyotrophic lateral sclerosis

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Fused in sarcoma (FUS) protein is linked to neurodegenerative diseases like amyotrophic lateral sclerosis (ALS).
• The precise mechanisms of FUS-induced neurotoxicity remain unclear.
• Understanding FUS pathogenesis is crucial for developing effective therapeutic strategies.

Purpose of the Study:

• To investigate the role of parkin in mitigating FUS-induced neurotoxicity.
• To elucidate the molecular mechanisms underlying parkin-mediated neuroprotection against FUS.

Main Methods:

• Utilized Drosophila melanogaster as a model organism to study FUS-induced phenotypes.
• Assessed locomotive defects in larvae and adult flies.
• Quantified FUS protein levels and mitochondrial complex I and III subunit assembly.
• Measured ATP levels to evaluate mitochondrial function.

Main Results:

• Parkin overexpression suppressed locomotive defects in FUS-expressing Drosophila without altering FUS levels.
• FUS expression led to reduced mitochondrial complex I and III subunits and decreased ATP production.
• Parkin expression rescued these mitochondrial dysfunctions, restoring complex levels and ATP.

Conclusions:

• Parkin acts as a neuroprotective regulator against FUS-induced proteinopathy.
• Parkin recovers mitochondrial complex I and III protein levels, mitigating FUS toxicity.
• These findings enhance understanding of FUS-related ALS pathogenesis and potential therapeutic targets.